| | Year 1 | Years 1–5 | | Dementia cohort n = 37,138 | Reference cohort n = 37,138 | Difference (95% CI) | Dementia cohort n = 37,138 | Reference cohort
n = 37,138 | Difference (95% CI) |
| Costs CAD$ (SD) | | | | | | | Prescription drugs | | | | | | | Cholinesterase inhibitors | 1,285 (651) | n/a | 1,285 (1,278–1,292) | 3,638 (3,335) | n/a | 3,638 (3,603–3,672) | Other drugs | 1,635 (1,766) | 1,677 (2,054) | −42 (−70–−15) | 5,581 (6,952) | 6,899 (10,160) | −1,318 (−1,442–−1,192) | Total drugs | 2,920 (2,016) | 1,677 (2,054) | 1,243 (1,213–1,271) | 9,219 (8,974) | 6,899 (10,160) | 2,320 (2,182–2,458) | Physician encounters | 997 (1,274) | 1,056 (1,726) | −60 (−81–−38) | 2,681 (2,760) | 2,777 (3,636) | −96 (−142–−49) | Hospitalizations | 3,691 (8,631) | 2,644 (8,083) | 1,047 (937–1,168) | 10,956 (17,054) | 7,603 (15,093) | 3,353 (3,122–3,585) | Institutionalizations | 753 (5,894) | 71 (1,843) | 682 (619–745) | 15,344 (57,649) | 1,763 (21,529) | 13,581 (12,955–14,207) |
| Total health care | 8,360 (11,667) | 5,448 (9,970) | 2,912 (2,756–3,068) | 38,200 (62,180) | 19,041 (31,404) | 19,159 (18,450–19,867) |
|
|